Thermo Fisher Scientific, headquartered in Waltham, Massachusetts, employs 122,000 and provides analytical instruments, reagents, and services across various segments, including Life Sciences and Specialty Diagnostics. Their offerings support research, drug production, and diagnostics in multiple fields.
TMO has been in the news recently: AstraZeneca plc plans to invest $50 billion in the United States by 2030, while Thermo Fisher Scientific Inc. reported adjusted earnings of $5.36 per share for Q2 2025, surpassing expectations. Additionally, there has been notable interest in Thermo Fisher from financial giants, with 49 unusual options trades observed in recent analysis.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.